A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Taraneh Mousavi; Behzad Fatemi; Shekoufeh Nikfar; Mohammad Ali Sahraian

• View Article